Cipher Pharmaceuticals Stock Technical Analysis
| CPHRF Stock | USD 10.71 0.17 1.61% |
As of the 10th of February, Cipher Pharmaceuticals shows the Risk Adjusted Performance of 0.0271, downside deviation of 2.0, and Mean Deviation of 1.45. Cipher Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Cipher Pharmaceuticals, which can be compared to its peers. Please confirm Cipher Pharmaceuticals jensen alpha, as well as the relationship between the potential upside and skewness to decide if Cipher Pharmaceuticals is priced correctly, providing market reflects its regular price of 10.71 per share. Given that Cipher Pharmaceuticals has jensen alpha of 0.0012, we suggest you to validate Cipher Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.
Cipher Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cipher, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CipherCipher |
Cipher Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cipher Pharmaceuticals' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cipher Pharmaceuticals.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Cipher Pharmaceuticals on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Cipher Pharmaceuticals or generate 0.0% return on investment in Cipher Pharmaceuticals over 90 days. Cipher Pharmaceuticals is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada More
Cipher Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cipher Pharmaceuticals' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cipher Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.0 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 9.32 | |||
| Value At Risk | (2.12) | |||
| Potential Upside | 3.83 |
Cipher Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cipher Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cipher Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cipher Pharmaceuticals historical prices to predict the future Cipher Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0271 | |||
| Jensen Alpha | 0.0012 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0907 |
Cipher Pharmaceuticals February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0271 | |||
| Market Risk Adjusted Performance | 0.1007 | |||
| Mean Deviation | 1.45 | |||
| Semi Deviation | 1.95 | |||
| Downside Deviation | 2.0 | |||
| Coefficient Of Variation | 3837.32 | |||
| Standard Deviation | 2.1 | |||
| Variance | 4.4 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 0.0012 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0907 | |||
| Maximum Drawdown | 9.32 | |||
| Value At Risk | (2.12) | |||
| Potential Upside | 3.83 | |||
| Downside Variance | 3.99 | |||
| Semi Variance | 3.82 | |||
| Expected Short fall | (1.60) | |||
| Skewness | (0.25) | |||
| Kurtosis | 5.08 |
Cipher Pharmaceuticals Backtested Returns
At this point, Cipher Pharmaceuticals is not too volatile. Cipher Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.1, which signifies that the company had a 0.1 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Cipher Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Cipher Pharmaceuticals' Downside Deviation of 2.0, risk adjusted performance of 0.0271, and Mean Deviation of 1.45 to double-check if the risk estimate we provide is consistent with the expected return of 0.19%. Cipher Pharmaceuticals has a performance score of 8 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cipher Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cipher Pharmaceuticals is expected to be smaller as well. Cipher Pharmaceuticals right now shows a risk of 1.87%. Please confirm Cipher Pharmaceuticals sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Cipher Pharmaceuticals will be following its price patterns.
Auto-correlation | -0.08 |
Very weak reverse predictability
Cipher Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Cipher Pharmaceuticals time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cipher Pharmaceuticals price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Cipher Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Cipher Pharmaceuticals technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Cipher Pharmaceuticals Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Cipher Pharmaceuticals across different markets.
About Cipher Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cipher Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cipher Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Cipher Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Cipher Pharmaceuticals. By analyzing Cipher Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cipher Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cipher Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Cipher Pharmaceuticals February 10, 2026 Technical Indicators
Most technical analysis of Cipher help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cipher from various momentum indicators to cycle indicators. When you analyze Cipher charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0271 | |||
| Market Risk Adjusted Performance | 0.1007 | |||
| Mean Deviation | 1.45 | |||
| Semi Deviation | 1.95 | |||
| Downside Deviation | 2.0 | |||
| Coefficient Of Variation | 3837.32 | |||
| Standard Deviation | 2.1 | |||
| Variance | 4.4 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 0.0012 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0907 | |||
| Maximum Drawdown | 9.32 | |||
| Value At Risk | (2.12) | |||
| Potential Upside | 3.83 | |||
| Downside Variance | 3.99 | |||
| Semi Variance | 3.82 | |||
| Expected Short fall | (1.60) | |||
| Skewness | (0.25) | |||
| Kurtosis | 5.08 |
Cipher Pharmaceuticals February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cipher stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 10.56 | ||
| Daily Balance Of Power | 2.43 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 10.68 | ||
| Day Typical Price | 10.69 | ||
| Price Action Indicator | 0.12 |
Complementary Tools for Cipher OTC Stock analysis
When running Cipher Pharmaceuticals' price analysis, check to measure Cipher Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cipher Pharmaceuticals is operating at the current time. Most of Cipher Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cipher Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cipher Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cipher Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |